However, we have previously found that only a minor proportion of GRHL2 binding sites in the genome of breast cancer cell lines coincide with ER⍺ binding sites,41 and in our current study no ER⍺ motif was identified in the vicinity of the GRHL2 peak in the NT5E gene. This evidence concerns the gene GRHL2 and breast carcinoma.